Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under the provision of the Companies Act, VII of 1913. Its Shares are listed on two stock exchanges in India i.e Bombay Stock Exchange and National Stock Exchange. The company has decades of presence in the Indian Pharma market and a strong foothold in the international market.

Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs).

Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Business area of the company

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets.

Indoco Remedies Ltd.

Shilpa Medicare Ltd.

Unichem Laboratories Ltd.

Wockhardt Ltd.

IOL Chemicals And Pharmaceuticals Ltd.

Gufic Biosciences Ltd.

Advanced Enzyme Technologies Ltd.

Dishman Carbogen Amcis Ltd.

Orchid Pharma Ltd.

Hikal Ltd.

Supriya Lifescience Ltd.

Sequent Scientific Ltd.

RPG Life Sciences Ltd.

Alembic Ltd.

Morepen Laboratories Ltd.

Open Price	340.05	Volume	159
Prev. Close	340.05

Performance